Treatment of Refractory Diabetic Macular Edema With Infliximab

Summary

The purpose of this study is to determine if treatment with infliximab improves macular edema which is refractory to laser photocoagulation in patients with diabetes.

Timeline

Start

2007-07

Primary completion

2008-12

Completion

2008-12

Publications

• Sfikakis PP, Grigoropoulos V, Emfietzoglou I, Theodossiadis G, Tentolouris N, Delicha E, Katsiari C, Alexiadou K, Hatziagelaki E, Theodossiadis PG. Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study. Diabetes Care. 2010 Jul;33(7):1523-8. doi: 10.2337/dc09-2372. Epub 2010 Apr 22.

Drugs

Indications